Resolution 7/2020 — Withania somnifera
Root amount, withanolides, specification and recommended warning in Poland


EU + POLAND EVIDENCE PROFILE
A root-based botanical where plant part, extraction details, withanolide exposure and Polish label wording all affect the review.
IDENTITY BEFORE STATUS
CLAIMS
The EU Register explains that some botanical function claims remain under consideration. This profile therefore does not present a marketing claim as authorised.
RESTRICTIONS
Polish GIS Team Resolution 7/2020 sets powdered root below 3 g in the recommended daily portion.
The same opinion sets a maximum of 10 mg total withanolides in the recommended daily portion and calls for a quantitative specification.
Its recommended warning excludes children, pregnancy and lactation and addresses sedative, sleep and antiepileptic medicines.
POLISH NOTES
Treat Resolution 7/2020 as an ingredient-specific Polish review layer and preserve its scope: Withania somnifera, adult supplements and the specified daily portion.
A product notification is not an approval. Formula, labelling, claims and presentation still need product-level review.
PRIMARY SOURCES
Root amount, withanolides, specification and recommended warning in Poland
Orientation only; exact identity, form and history remain operator evidence
Claims status and the separate treatment of botanical claims under consideration